Nyxoah SA (EBR:NYXH)
1.392
+0.124 (9.78%)
Aug 10, 2026, 4:00 PM EDT
Nyxoah Revenue
Nyxoah had revenue of 7.68M EUR in the quarter ending June 30, 2026, with 472.76% growth. This brings the company's revenue in the last twelve months to 21.66M, up 339.14% year-over-year. In the year 2025, Nyxoah had annual revenue of 10.02M with 121.63% growth.
Revenue (ttm)
21.66M
Revenue Growth
+339.14%
P/S Ratio
6.43
Revenue / Employee
140.67K
Employees
154
Market Cap
139.30M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.02M | 5.50M | 121.63% |
| Dec 31, 2024 | 4.52M | 173.00K | 3.98% |
| Dec 31, 2023 | 4.35M | 1.26M | 40.99% |
| Dec 31, 2022 | 3.08M | 2.23M | 261.97% |
| Dec 31, 2021 | 852.00K | 783.00K | 1,134.78% |
| Dec 31, 2020 | 69.00K | - | - |
| Dec 31, 2019 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| UCB SA | 8.52B |
| argenx SE | 4.65B |
| Fagron NV | 1.03B |
| Ion Beam Applications | 620.18M |
| European Medical Solutions | 52.80M |
| Hyloris Pharmaceuticals | 7.94M |
| Onward Medical | 5.41M |
| Sequana Medical NV | 105.50K |
Nyxoah News
- 4 days ago - Nyxoah price target lowered to $2.31 from $2.86 at Baird - TheFly
- 4 days ago - Nyxoah price target lowered to $6 from $7 at Piper Sandler - TheFly
- 4 days ago - Nyxoah price target lowered to $4 from $13 at Oppenheimer - TheFly
- 5 days ago - Nyxoah Q2 Earnings Call Highlights - MarketBeat
- 5 days ago - Nyxoah Earnings Call Transcript: Q2 2026 - Transcripts
- 5 days ago - Nyxoah Earnings release: Q2 2026 - Filings
- 5 days ago - Nyxoah Reports Second Quarter and First Half 2026 Financial and Operating Results - GlobeNewsWire
- 14 days ago - Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026 - GlobeNewsWire